- B2B
- Has physical offices
- Publicly traded
- Pharma & life sciences
- Has in-house R&D
About Editas Medicine
A clinical stage genome editing company focused on using CRISPR technology to develop transformative treatments for serious diseases worldwide
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- Cambridge, Massachusetts, United States
- Founded
- 2013
- Revenue
- $40.5MFY2025, publicly reported
- Website
- editasmedicine.com
Who should you contact at Editas Medicine?
Connect to Tamtam to see the decision-makers at Editas Medicine, with verified emails and phone numbers, and find more companies like it.
See who to contact, freeEditas Medicine at a glance
Editas Medicine is a B2B company in the Biotechnology Research industry, headquartered in Cambridge, Massachusetts, United States.
Editas Medicine was founded in 2013.
Editas Medicine has 51–250 employees.
Editas Medicine's revenue is $40.5M (FY2025, publicly reported).
Frequently asked questions about Editas Medicine
What is Editas Medicine's revenue?
Editas Medicine's revenue is $40.5M (FY2025, publicly reported).
How many employees does Editas Medicine have?
Editas Medicine has 51–250 employees.
Where is Editas Medicine headquartered?
Editas Medicine is headquartered in Cambridge, Massachusetts, United States.
Selling to companies like Editas Medicine?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies